These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre. Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose]. Bakker SC; Zanin DE; Zweers EJ Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370 [TBL] [Abstract][Full Text] [Related]
6. Acute changes in thyroid volume and function following 131I therapy of multinodular goitre. Nygaard B; Faber J; Hegedüs L Clin Endocrinol (Oxf); 1994 Dec; 41(6):715-8. PubMed ID: 7889605 [TBL] [Abstract][Full Text] [Related]
7. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results]. Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510 [TBL] [Abstract][Full Text] [Related]
11. Outpatient management of patients with large multinodular goitres treated with fractionated radioiodine. Howarth DM; Epstein MT; Thomas PA; Allen LW; Akerman R; Lan L Eur J Nucl Med; 1997 Dec; 24(12):1465-9. PubMed ID: 9391180 [TBL] [Abstract][Full Text] [Related]
12. Iodine isotope ¹³¹I therapy for toxic nodular goitre: treatment efficacy parameters. Szumowski P; Rogowski F; Abdelrazek S; Kociura-Sawicka A; Sokolik-Ostasz A Nucl Med Rev Cent East Eur; 2012 Apr; 15(1):7-13. PubMed ID: 23047567 [TBL] [Abstract][Full Text] [Related]
13. [Therapy for non-toxic multinodular goiter: radioiodine therapy as attractive alternative to surgery]. Dietlein M; Dederichs B; Kobe C; Theissen P; Schmidt M; Schicha H Nuklearmedizin; 2006; 45(1):21-34; quiz N1-2. PubMed ID: 16493511 [TBL] [Abstract][Full Text] [Related]
14. 131-I radioiodine therapy for hyperthyroidism in patients with Graves' disease, uninodular goitre and multinodular goitre. Danaci M; Feek CM; Notghi A; Merrick MV; Padfield PL; Edwards CR N Z Med J; 1988 Nov; 101(858):784-6. PubMed ID: 3194075 [TBL] [Abstract][Full Text] [Related]
15. [The treatment of multinodular large non-toxic goiter using repeated doses of radioiodine (preliminary report)]. Pisarek M; Baczyk M; Gryczyńska M; Sowiński J Endokrynol Pol; 2007; 58(1):18-26. PubMed ID: 17354201 [TBL] [Abstract][Full Text] [Related]
16. Development of hypothyroidism during long-term follow-up of patients with toxic nodular goitre after radioiodine therapy. Kahraman D; Keller C; Schneider C; Eschner W; Sudbrock F; Schmidt M; Schicha H; Dietlein M; Kobe C Clin Endocrinol (Oxf); 2012 Feb; 76(2):297-303. PubMed ID: 21854403 [TBL] [Abstract][Full Text] [Related]
17. Radioiodine - an attractive alternative to surgery in large non-toxic multinodular goitres. Kaniuka S; Lass P; Sworczak K Nucl Med Rev Cent East Eur; 2009; 12(1):23-9. PubMed ID: 19554518 [TBL] [Abstract][Full Text] [Related]
18. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH). Bonnema SJ; Nielsen VE; Hegedüs L Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838 [TBL] [Abstract][Full Text] [Related]
19. Long-term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity. Roque C; Santos FS; Pilli T; Dalmazio G; Castagna MG; Pacini F J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32320467 [TBL] [Abstract][Full Text] [Related]
20. [Does Iodine 131 treatment of goiter result in an acute increase of the volume and function of the thyroid gland?]. Nygaard B; Faber JO; Hegedüs L Ugeskr Laeger; 1995 Dec; 157(50):7003-6. PubMed ID: 8545918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]